Aerosol deposition considerations in inhalation therapy

Area of Science:

• Pulmonary Medicine
• Pharmacology
• Biomedical Engineering

Background:

• Effective aerosol therapy relies on efficient drug delivery to the lungs, often a small fraction of the total dose.
• Drug deposition in the lungs is influenced by inhalation patterns, particle size, and airway conditions.
• Many patients struggle with correct metered-dose inhaler (MDI) technique, impacting therapeutic efficacy.

Purpose of the Study:

• To analyze factors influencing aerosol drug deposition in the lungs.
• To evaluate methods for enhancing lung deposition from inhaler devices.
• To provide guidance on optimizing aerosol therapy delivery.

Main Methods:

• Review of aerosol deposition mechanisms (inertial impaction, gravitational sedimentation).
• Analysis of inhalation techniques and their effect on lung deposition.
• Evaluation of extension devices (spacers, holding chambers) for MDIs.
• Assessment of nebulizer parameters (droplet size, fill volume, flow rate).

Main Results:

• Lung deposition from inhalers is typically low (around 10%) but critical for efficacy.
• Correct MDI use (coordinated actuation, slow inhalation, breath-holding) improves lung delivery.
• Extension devices significantly improve MDI usability and lung deposition while reducing oral deposition.
• Nebulizer performance is optimized by selecting devices with small droplet sizes and appropriate operational parameters.

Conclusions:

• Patient technique and device choice are key determinants of successful aerosol therapy.
• Extension devices offer a practical solution to improve MDI effectiveness and reduce side effects.
• Optimizing nebulizer use requires attention to device characteristics and operational settings for maximal lung delivery.